These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35568295)

  • 1. Small cell lung cancer: Novel treatments beyond immunotherapy.
    Meijer JJ; Leonetti A; Airò G; Tiseo M; Rolfo C; Giovannetti E; Vahabi M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):376-385. PubMed ID: 35568295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
    Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
    Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective.
    Walia HK; Sharma P; Singh N; Sharma S
    Curr Treat Options Oncol; 2022 Feb; 23(2):268-294. PubMed ID: 35226309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal pathways and precision therapy of small-cell lung cancer.
    Yuan M; Zhao Y; Arkenau HT; Lao T; Chu L; Xu Q
    Signal Transduct Target Ther; 2022 Jun; 7(1):187. PubMed ID: 35705538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
    Caliman E; Fancelli S; Petroni G; Gatta Michelet MR; Cosso F; Ottanelli C; Mazzoni F; Voltolini L; Pillozzi S; Antonuzzo L
    Lung Cancer; 2023 Jan; 175():88-100. PubMed ID: 36493578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking the Impasse: Advances in Treatment of Small Cell Lung Cancer.
    Saltos A; Antonia S
    Clin Chest Med; 2020 Jun; 41(2):269-280. PubMed ID: 32402362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for small cell lung cancer: established applications and novel approaches.
    Scott SC; Hann CL
    Clin Adv Hematol Oncol; 2021 Oct; 19(10):654-663. PubMed ID: 34637432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunotherapy in small cell lung cancer.
    Calles A; Aguado G; Sandoval C; Álvarez R
    Clin Transl Oncol; 2019 Aug; 21(8):961-976. PubMed ID: 30637710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
    Gadgeel SM
    Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
    Spigel DR; Socinski MA
    J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DNA damage in SCLC.
    Foy V; Schenk MW; Baker K; Gomes F; Lallo A; Frese KK; Forster M; Dive C; Blackhall F
    Lung Cancer; 2017 Dec; 114():12-22. PubMed ID: 29173760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new hope: the immunotherapy in small cell lung cancer.
    Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
    Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges.
    Pavan A; Attili I; Pasello G; Guarneri V; Conte PF; Bonanno L
    J Immunother Cancer; 2019 Aug; 7(1):205. PubMed ID: 31383005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients.
    Lorenzi M; Resi MV; Bonanno L; Frega S; Dal Maso A; Ferro A; Guarneri V; Pasello G
    Front Immunol; 2024; 15():1308109. PubMed ID: 38348046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Are the Biomarkers for Immunotherapy in SCLC?
    Longo V; Catino A; Montrone M; Pizzutilo P; Annese T; Pesola F; Marech I; Cassiano S; Ribatti D; Galetta D
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive biomarkers for immunotherapy response in extensive-stage SCLC.
    Zhu L; Qin J
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):22. PubMed ID: 38245636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Development of Immunotherapy for Small Cell Lung Cancer].
    Yu T; Zhong D
    Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):918-923. PubMed ID: 30591100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy Advances in Small Cell Lung Cancer].
    Xu Y; Zhan P; Song Y
    Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):989-998. PubMed ID: 32752583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.
    Xiong J; Barayan R; Louie AV; Lok BH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):521-542. PubMed ID: 35917883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facts and Hopes on Cancer Immunotherapy for Small Cell Lung Cancer.
    Zugazagoitia J; Osma H; Baena J; Ucero AC; Paz-Ares L
    Clin Cancer Res; 2024 Jul; 30(14):2872-2883. PubMed ID: 38630789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.